Centre for Family Research, Cambridge CB2 3RF, UK.
Reprod Biomed Online. 2012 Jun;24(7):698-708. doi: 10.1016/j.rbmo.2012.02.008. Epub 2012 Feb 27.
Egg-sharing schemes involve a woman sharing a portion of her eggs with another in exchange for free or reduced-cost fertility treatment and have been regulated in the UK since 1998. However, while being perceived as a unique anomaly (within the UK system) such schemes have caused considerable debate. Some critics have been concerned that the benefit-in-kind (i.e. fertility treatment) offered in exchange for donating eggs might compromise the consent of potential donors, particularly those who have no other means to access treatment, and lead to exploitation and the commodification of gametes. This article reports empirical findings that engage directly with these concerns. First, data on the demographic characteristics, circumstances and treatment outcomes of donors and recipients are presented, followed by data on egg sharers' own retrospective assessments of egg-sharing and their opinions regarding its ethics and regulation. This study shows that, contrary to some expectations, there are very few differences in the characteristics, experiences and opinions of egg-sharing donors and recipients, and also highlights the overwhelmingly positive assessment of egg-sharing by women who have taken part in such schemes.
卵子共享计划涉及一名女性与另一名女性分享一部分卵子，以换取免费或降低成本的生育治疗，自 1998 年以来在英国受到监管。然而，尽管这种计划在英国体系中被视为一种独特的异常现象，但引起了相当大的争议。一些批评者担心，以实物形式（即生育治疗）换取捐赠卵子可能会损害潜在捐赠者的同意，特别是那些没有其他途径获得治疗的人，并导致配子的剥削和商品化。本文报告了直接涉及这些问题的实证研究结果。首先，介绍了供体和受体的人口统计学特征、情况和治疗结果的数据，然后介绍了卵子共享者对卵子共享的回顾性评估及其对其伦理和监管的看法的数据。这项研究表明，与一些预期相反，卵子共享供体和受体的特征、经验和观点几乎没有差异，也突出了参与此类计划的女性对卵子共享的压倒性积极评价。
